Medical Information

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

Not a healthcare professional? Go to the patient or caregiver website.

TALAPRO-1: Talazoparib Monotherapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Tumor DNA Damage Response Alterations(DDRm) — Exploration of Genomic Loss of Heterozygosity (gLOH) and Potential Associations With Antitumor Activity

Oral Presentation
de Bono JS, Mehra N, Laird AD, Castro E, Barthelemy P, Delva R, Scagliotti GV, Maruzzo M, Stirling A, Machiels J-P,  Dumez H, Renard V, Hopkins JF, Albacker LA, Chen H-C, Healy CG,  Chelliserry J, Dorff T, Fizazi K April 11, 2022 AACR 2022 Prostate Cancer